CLINICAL_TRIALS
trial_result
· 2014-09-26
Clinical Trial Update: Vismodegib for Treatment of Basal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial of vismodegib for basal cell carcinoma has completed enrollment with results posted in September 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abel Torres, MD | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-26